HCA Healthcare, Inc. (NYSE:HCA) today announced that its wholly owned subsidiary, HCA Inc., proposes to offer senior notes, subject to market and other considerations. Actual terms of the senior notes, including
HCA Healthcare hospitals earned more 2027 specialty care recognitions than any other health system, including national distinctions for surgical care, emergency medicine and orthopedic surgery
HCA Healthcare, Inc.
HCA Healthcare, Inc. (NYSE:HCA) today announced financial and operating results for the third quarter ended September 30, 2026.
Key third quarter metrics (all percentage changes compare 3Q 2026 to 3Q 2025 unless
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced it will host its eighth annual "Crush the Crisis" national prescription drug take back day. On Saturday, Oct.
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact
HCA Healthcare, Inc. (NYSE:HCA) announces the following Webcast:
What: HCA Healthcare, Inc. 3Q 2026 Earnings Call
When: Tuesday, October 27, 2026, at 9:00 AM Central (10:00 AM Eastern)
How: Live Audio over the
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today presented its annual HCA Healthcare Awards of Distinction at a ceremony in Nashville, Tennessee. The HCA Healthcare Awards of
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact
HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that it has completed the previously announced acquisition of The College of Health Care Professions (CHCP).
As
NEW YORK, Sept. 3, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE: HCA). Such investors are advised to contact
HCA Healthcare, Inc. (NYSE:HCA) is scheduled to present at the following healthcare conferences:
September 9, 2026, at 10:15am ET at the Wells Fargo Healthcare Conference
September 15, 2026, at 1:50pm CT at the
NEW YORK, Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE:HCA). Such investors are advised to contact
HCA Healthcare, Inc. (NYSE:HCA) today announced that Michael Schlosser, M.D., MBA, senior vice president and chief transformation officer, has been appointed executive vice president and chief clinical officer,
If you purchased or acquired stock in HCA and would like to discuss your legal rights, contact Bragar Eagel & Squire partners Brandon Walker or Melissa Fortunato by email at investigations@bespc.com or by telephone
NEW YORK, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of HCA Healthcare, Inc. ("HCA" or the "Company") (NYSE:HCA). Such investors are advised to
